Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
2019 · The Lancet · 2,820 citations
https://doi.org/10.1016/s0140-6736(19)31149-3
A
André C. Carpentier
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
326
Papers
19.3K
Citations
63
h-index
170
i10-index
André C. Carpentier is an academic researcher from Centre Hospitalier Universitaire de Sherbrooke. The author has contributed to research in topics: Adipose Tissue and Metabolism & Diet and metabolism studies & Cardiovascular Disease and Adiposity. The author has an h-index of 63, co-authored 278 publications.
ORCID: 0000-0002-3983-8156Papers by this author
worksDulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial
2019 · The Lancet · 600 citations
https://doi.org/10.1016/s0140-6736(19)31150-x
Inhibition of Intracellular Triglyceride Lipolysis Suppresses Cold-Induced Brown Adipose Tissue Metabolism and Increases Shivering in Humans
2017 · Cell Metabolism · 189 citations
https://doi.org/10.1016/j.cmet.2016.12.005
Effect of Alipogene Tiparvovec (AAV1-LPL<sup>S447X</sup>) on Postprandial Chylomicron Metabolism in Lipoprotein Lipase-Deficient Patients
2012 · The Journal of Clinical Endocrinology & Metabolism · 163 citations
https://doi.org/10.1210/jc.2011-3002
Brown Adipose Tissue—A Translational Perspective
2022 · Endocrine Reviews · 158 citations
https://doi.org/10.1210/endrev/bnac015
Dietary fatty acid metabolism of brown adipose tissue in cold-acclimated men
2017 · Nature Communications · 145 citations
https://doi.org/10.1038/ncomms14146
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat